Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
NCI Community Cancer Center Pilot Program Patient Survey
This study is currently recruiting participants.
Verified by National Institutes of Health Clinical Center (CC), October 2008
Sponsored by: National Cancer Institute (NCI)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00786656
  Purpose

Background:

The NCI Community Cancer Centers Pilot Program (NCCCP), http://ncccp.cancer.gov, is a three-year pilot program to test the concept of a national network of community cancer centers to expand cancer research and deliver the latest, most advanced cancer care to a greater number of Americans in the communities in which they live. The pilot program is designed to encourage the collaboration of private-practice medical, surgical, and radiation oncologists, with close links to NCI research and to the network of 63 NCI-designated Cancer Centers principally based at large research universities. NCI contracted with RTI International (www.rti.org) to conduct a comprehensive evaluation of NCCCP pilot program using multiple methodologies, including a survey of cancer patients receiving care at the pilot sites.

Objectives:

The goal of the patient survey is to gain an understanding of the clinical experiences of adult patients who receive services at the NCCCP pilot sites and to assess if and how their experience changes over the pilot period. Specifically, the survey instrument seeks to collect data about patients' information needs and awareness of the NCCCP program; clinical trials experience; access to health care; perspectives on patient-provider communication; and experiences with patient navigation, self-management, medical decision making, and survivorship; as well as their satisfaction with care and quality of life.

Eligibility:

Each of the ten participating Centers will create a de-identified electronic file of all patients who meet the inclusion criteria: 1) patient treated for at least3 months at the Cancer Center since July 1, 2007; 2) patient is age 21 years or older at time of diagnosis; and 3) patient was diagnosed with cancer based on specific ICD and/or CPT codes. Centers will create this file using their cancer registry and assign each individual a unique identification (ID) numbers.

Design:

Each file containing the universe of eligible patients will be sent to RTI, from which 475 patients from each Center's list will be randomly selected. RTI will send a list back to each Center indicating which 475 patient IDs were selected for inclusion in the survey. The Center staff will match each selected patient back to their master list using the Study ID number to identify patients included in the survey. RTI will deliver 475 pre-paid patient survey packets to each Center. The packets will include all required items except a Patient Notification Letter, which is a cover letter introducing the study and provides instructions on how to complete the survey. To protect patient privacy, Center staff will be responsible for generating the mailing labels and personalized Patient Notification Letter, and mailing the packets.


Condition
Malignant Neoplasms

MedlinePlus related topics: Cancer
U.S. FDA Resources
Study Type: Observational
Study Design: Retrospective
Official Title: NCI Community Cancer Center Pilot Program Patient Survey

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 3000
Study Start Date: November 2008
Detailed Description:

Background:

The NCI Community Cancer Centers Pilot Program (NCCCP), http://ncccp.cancer.gov, is a three-year pilot program to test the concept of a national network of community cancer centers to expand cancer research and deliver the latest, most advanced cancer care to a greater number of Americans in the communities in which they live. The pilot program is designed to encourage the collaboration of private-practice medical, surgical, and radiation oncologists, with close links to NCI research and to the network of 63 NCI-designated Cancer Centers principally based at large research universities. NCI contracted with RTI International (www.rti.org) to conduct a comprehensive evaluation of NCCCP pilot program using multiple methodologies, including a survey of cancer patients receiving care at the pilot sites.

Objectives:

The goal of the patient survey is to gain an understanding of the clinical experiences of adult patients who receive services at the NCCCP pilot sites and to assess if and how their experience changes over the pilot period. Specifically, the survey instrument seeks to collect data about patients' information needs and awareness of the NCCCP program; clinical trials experience; access to health care; perspectives on patient-provider communication; and experiences with patient navigation, self-management, medical decision making, and survivorship; as well as their satisfaction with care and quality of life.

Eligibility:

Each of the ten participating Centers will create a de-identified electronic file of all patients who meet the inclusion criteria: 1) patient treated for at least3 months at the Cancer Center since July 1, 2007; 2) patient is age 21 years or older at time of diagnosis; and 3) patient was diagnosed with cancer based on specific ICD and/or CPT codes. Centers will create this file using their cancer registry and assign each individual a unique identification (ID) numbers.

Design:

Each file containing the universe of eligible patients will be sent to RTI, from which 475 patients from each Center's list will be randomly selected. RTI will send a list back to each Center indicating which 475 patient IDs were selected for inclusion in the survey. The Center staff will match each selected patient back to their master list using the Study ID number to identify patients included in the survey. RTI will deliver 475 pre-paid patient survey packets to each Center. The packets will include all required items except a Patient Notification Letter, which is a cover letter introducing the study and provides instructions on how to complete the survey. To protect patient privacy, Center staff will be responsible for generating the mailing labels and personalized Patient Notification Letter, and mailing the packets.

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria
  • INCLUSION CRITERIA:
  • Patients who are listed on an NCCCP site's cancer registry who are assigned to selected cancer diagnosis and treatment codes
  • Cancer patients age 21 years and older at the time of sampling
  • Cancer patients treated at least 3 months at their cancer center since July 1, 2007

EXCLUSION CRITERIA:

  • Persons under the age of 21 at the time of sampling
  • Persons who do not have a specified cancer diagnosis or treatment code
  • Cancer patients without at least 3 months of treatment information since July 1, 2007
  • Cancer patients who are deceased at the time of sampling
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00786656

Contacts
Contact: Steven B. Clauser, Ph.D. (301) 496-8500 clausers@mail.nih.gov

Locations
United States, North Carolina
Research Triangle Institute International Recruiting
Research Triangle Park, North Carolina, United States, 27709
Sponsors and Collaborators
  More Information

Study ID Numbers: 999909026, 09-C-N026
Study First Received: November 5, 2008
Last Updated: November 5, 2008
ClinicalTrials.gov Identifier: NCT00786656  
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Cancer
Adults
Treatment
Patient Experience

Additional relevant MeSH terms:
Neoplasms

ClinicalTrials.gov processed this record on January 16, 2009